{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-018505","form_type":"8-K","ticker":"HIND","cik":"0001427570","company_name":"Vyome Holdings, Inc","filed_at":"2023-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.896459+00:00","generated_at":"2026-06-19T17:49:44.473430+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ReShape Lifesciences closes upsized $10.2M public offering of units with warrants","bullets":["Offered 1,275,000 units at $8.00/unit; each unit: 1 share (or pre-funded warrant) + 1 warrant for 1.5 shares.","Gross proceeds $10.2M; net proceeds ~$9.1M after underwriting discounts and expenses.","Warrants: exercise price $8.00/share, 5-year term; alternative cashless exercise yields 0.75 shares per warrant.","Overallotment exercised for additional warrants to purchase 286,875 shares of common stock.","Proceeds to fund growth strategies, working capital, and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-018505","json":"https://secwatch.observer/filing/0001104659-23-018505.json","markdown":"https://secwatch.observer/filing/0001104659-23-018505.md","text":"https://secwatch.observer/filing/0001104659-23-018505.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427570/000110465923018505/0001104659-23-018505-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427570/000110465923018505/tm236268d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T17:49:44.473430+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0d99a35346e90dbe9b4ae15cfd07ef25db53017c","claim":"Vyome Holdings, Inc entered into Underwriting Agreement with Maxim Group LLC valued at $8.00 per Unit (effective 2023-02-06).","evidence_excerpt":"On February 6, 2023, ReShape Lifesciences Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Maxim Group LLC","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1427570/000110465923018505/0001104659-23-018505-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Maxim Group LLC"},{"label":"Value","value":"$8.00 per Unit"},{"label":"Effective","value":"2023-02-06"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}